Table 3.
All cohort (n=97) | |
---|---|
Ejection fraction | 60 [57.5–65] |
Peak pressure gradient, mm Hg | 15.5 [12–25] |
Mean pressure gradient, mm Hg | 8 [6–14] |
PVL, mild | 42 (45.2) |
PVL, moderate | 7 (7.5) |
Pulmonary hypertension, mm Hg | 36 [29.5–44.5] |
Mitral regurgitation, ≥mild | 50 (54.3) |
Tricuspid regurgitation, ≥mild | 52 (56.5) |
Mitral stenosis, ≥moderate | 13 (14.1) |
RV failure | 4 (4.3) |
Beta blockers | 52 (56.5) |
Furosemide | 41 (44.6) |
Spironolactone | 8 (8.7) |
ACEi/ARB | 50 (54.3) |
Vasodilators | 28 (30.4) |
ACEi indicates angiotensin‐converting enzyme inhibitors; ARB, angiotensin receptor blockers; PVL, paravalvular leak; and RV, right ventricular.
Values are presented as n (%) or median [interquartile range].